ALM

Almonty Industries Inc. Common Shares
NASDAQBASIC MATERIALSOTHER INDUSTRIAL METALS & MINING

Key Statistics

Market Cap
$3.47B
P/E Ratio
EPS
$-0.44
Beta
2.05
52W High
$24.41
52W Low
$3.58
50-Day MA
$16.73
200-Day MA
$13.82
Dividend Yield
Profit Margin
-265.10%
Forward P/E
40.00
PEG Ratio

About Almonty Industries Inc. Common Shares

Almonty Industries Inc. engages in mining, processing, and shipping of tungsten concentrates. The company is headquartered in Dillon, Montana.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$50.01M
Gross Profit (TTM)$15.64M
EBITDA$-22.84M
Operating Margin8.83%
Return on Equity-70.70%
Return on Assets-3.31%
Revenue/Share (TTM)$0.22
Book Value$0.90
Price-to-Book14.97
Price-to-Sales (TTM)69.39
EV/Revenue104.78
EV/EBITDA-54.39
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)221.20%
Shares Outstanding$283.74M
Float$230.85M
% Insiders22.70%
% Institutions42.15%

Historical Volatility

HV 10-Day
96.03%
HV 20-Day
97.20%
HV 30-Day
85.37%
HV 60-Day
97.29%
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($24.90 target)
8
Buy
1
Hold

Latest News

Almonty to Voluntarily Delist From ASX

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1) announces that the Company has requested and received formal approval from the Australian Securities Exchange (“ASX”) to be removed from the official list of ASX pursuant to ASX Listing Rule 17.11 (“Delisting”), subject to the conditions described below. This follows the Company's decision to delist the common shares of the Company (“Shares”) from the Toront.

Business Wire7/23/2026Neutral
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has accepted the submission of the extension of the Marketing Authorisation Application (MAA) of Ebglyss® (lebrikizumab) for the treatment of children and adolescents aged 6 months to

Business Wire7/20/2026Neutral
Almonty to Voluntarily Delist From TSX

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it will voluntarily delist the common shares of the Company (the “Common Shares”) from the Toronto Stock Exchange (the “TSX”) effective as of the close of trading on July 31, 2026 (the “Delisting”). Following such date, the Common Shares will no longer be traded on the TSX, but will con.

Business Wire7/17/2026Neutral
Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1)

New York, July 16, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1).  The research summary below is from an issuer-sponsored report commissioned by Almonty Industries, Inc. and produced by Diamond Equity Research. The update note includes detailed information on the Almonty Industries' business model, services, industry overview, financials, valuation, management profile, and risks.

GlobeNewsWire7/16/2026Neutral
Almonty Commences Processing Operations at Sangdong Mine, Marking Transition to Saleable Tungsten Concentrate Production

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the commencement of processing plant throughput operations at its Sangdong Mine in Gangwon Province, South Korea. During June 2026, the Company began feeding stockpiled run-of-mine ore through its newly commissioned processing plant to produce saleable tungsten concentrate — a pivotal milest.

Business Wire7/1/2026Neutral
Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has joined the large-cap Russell 1000® Index and the broad-market Russell 3000® Index, effective with the opening of United States equity markets today, Monday, June 29, 2026, upon the conclusion of the 2026 Russell indexes reconstitution. The June 2026 reconstitution of the Russell.

Business Wire6/29/2026Neutral
Alliance Mining Appoints Jeffrey Selder, M.Eng., to Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Alliance Mining Corp. (TSXV: ALM) ("Alliance" or the "Company") is pleased to announce the appointment of Jeffrey Selder, M.Eng. (Mining) to the Company's Board of Directors, effective immediately.

Newsfile Corp6/18/2026Neutral
Orbit Makes PTC's Recent Pullback Interesting Despite Execution Risks

PTC Inc. still has a steady and recurring lifecycle software base with offerings across CAD, PLM, ALM, SLM, and general SaaS workflows. Their newer offerings, like Orbit and Jetstream, also move PTC towards a clearer AI integration path for its products and services. I do believe the sale of Kepware and ThingWorx changed its prospects a bit. In part, it streamlined PTC's business and helped finance stock buybacks.

Seeking Alpha6/16/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ALM and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More BASIC MATERIALS Stocks

Data last updated: 7/29/2026